MLchartDataset catalogue

valganciclovir

Term · Oncology and biomedicine · MLC-T-ONC-009153

  1. An antiviral agent that is being studied as a treatment for AIDS-related cytomegalovirus. It is changed in the body to ganciclovir.

  2. A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication.

Table 1. Record
IdentifierMLC-T-ONC-009153
FieldOncology and biomedicine
AbbreviationVGCV
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009153",
  "term": "valganciclovir",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An antiviral agent that is being studied as a treatment for AIDS-related cytomegalovirus. It is changed in the body to ganciclovir.",
    "A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication."
  ],
  "abbreviation": "VGCV",
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/valganciclovir/"
}

Record 17,094 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.